// App-Quantinova.ai

: Safety and Efficacy of Continuous Use Avatrombopag in Chronic Liver Disease

Researchers

Presenter

  • Sandra Mazzoni

Principal Investigators

  • Dana E. Angelini

Medical Centers

  • Department of Hematology and Medical Oncology, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Blood/haematological Diseases

  • Cardiovascular (CVS)

  • Gastroenterology (GU)

  • Pulmonary/Respiratory Diseases

Disease

  • Chronic Liver Disease

  • Venous thrombosis

  • Cirrhosis

Biomarkers

  • N/A

Drug/Treatment

  • Avatrombopag

Outcome

  • N/A

Study Design

  • Efficacy

  • Safety

  • Placebo Control

  • Multicenteric

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved